Trials / Unknown
UnknownNCT03609099
Adequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate Initial Clinical Response
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 424 (estimated)
- Sponsor
- David Garcia Cinca · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Non-inferiority, multicenter, prospective double-blind, randomized clinical trial of two parallel groups. The randomization between the 2 study groups will be carried out according to a scheme generated by a computer program, in blocks of 6 and stratified by centers. The antibiotic treatment will be evaluated during 5 days compared to the usual antibiotic treatment for more than 7 days in patients with community-acquired pneumonia with a Pneumonia Severity Index IV-V severity score who present an adequate response in the first 4 days of hospital antibiotic treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Moxifloxacin | 400 mg / day once a day oral treatment during 3 days. |
| DRUG | Placebo | once a day oral treatment during 3 days. |
Timeline
- Start date
- 2019-02-15
- Primary completion
- 2020-11-15
- Completion
- 2021-05-15
- First posted
- 2018-08-01
- Last updated
- 2019-12-05
Locations
5 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT03609099. Inclusion in this directory is not an endorsement.